Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu
about
Statins for primary prevention of venous thromboembolismHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisStatins for the primary prevention of cardiovascular diseaseStatins for primary prevention of venous thromboembolismRosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveStatin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled TrialsHigh-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysisLipid abnormalities in kidney disease and management strategiesManagement of coronary artery disease and acute coronary syndrome in the chronic kidney disease population-A review of the current literature.Neurological complications in chronic kidney disease patients.Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.Diabetic Nephropathy: New Risk Factors and Improvements in DiagnosisEffect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.Renal failure (chronic)Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced NephropathyBenefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis.Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in womenContrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses.Contrasting Cholesterol Management Guidelines for Adults with CKD.Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.Fibroblast growth factor 23 and Inflammation in CKDStatins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney diseaseLow-grade inflammation as trade-off causing chronic complex diseases.Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.Concomitant impact of high-sensitivity C-reactive protein and renal dysfunction in patients with acute myocardial infarctionEffects of statin treatment in patients with coronary artery disease and chronic kidney diseaseBenefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.Coronary artery calcification in chronic kidney disease: An update.Statins and renal disease: friend or foe?Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.
P2860
Q24187238-96414B71-CD94-432E-B7CC-81091EC1D80CQ24194514-ED016392-BEDC-4B9B-84FB-9706F25DFF64Q24201513-2713D938-EC1D-4B8C-A560-ED2F9D754068Q24204040-29121A86-ED24-4B02-886A-8F3AD629878EQ24594814-CA5D2A18-3352-4785-A927-2697B9D8CECBQ24602803-EF761792-E0AD-4B24-B2D6-4714E81B656FQ26801795-07D37F44-2BC4-46E5-BF89-70950DAFFF95Q26853061-AC289CE7-089E-437B-9CC4-2A0ACA2A34E5Q27024982-644177B6-634B-410E-A5C4-0FEAE8D591CBQ30238977-F25113B0-6562-4DC1-B87D-436387349737Q30252095-3866653A-59D4-4D5D-A164-4605FBCE3A13Q30651756-51939C94-6DF3-4A4C-ABF7-175BF47C6EDAQ33583018-F2EA7001-EEFA-461C-83B0-EFC6D14EA2F4Q33588706-D88243AF-08EC-4705-9995-2626922D3F41Q33910618-3828D8BB-F1C2-43D6-9FA6-DEA380A11EC1Q34269645-2496A6EF-B681-4E51-BF76-F93E74E175E1Q34304400-CE460CE6-3B46-496E-BD45-487F78A8752DQ34428322-78745AD5-FC2F-4973-9C53-C5D904E88AC8Q34445799-7C8354AE-E9F5-4CE9-865B-FBF526496EA6Q34455207-CFB76F3F-2C9A-440F-B3B0-389248F68F9CQ34613884-31879A8F-72C1-47BD-8C2C-FA275251D21DQ34636887-545660C8-552C-4FBE-B3B7-F1523DF8388DQ34736194-EC0A6428-878D-4FCD-9F83-219EE0DC8480Q34736818-64D2E616-8BFD-4A9E-AE64-86F8AD3DB3CBQ35172886-9B539021-3C6C-4719-A70A-60B292919C3CQ35550614-2BCFE0FF-00B7-4685-9688-8F12BFA3A3D1Q35576102-258FF6AE-72C3-41D6-935B-96B19D5CFB39Q36067879-EB2A814C-D761-469A-BBE7-1A0D2B090904Q36088110-6828FA8D-7728-4A2C-9792-944F896C6792Q36365884-3268C587-D5D7-4ED1-ACEA-4B7E543E4A9CQ36845662-3C487FEA-F926-494C-95ED-56EEAB4F6309Q36943996-3B71096E-7223-4BE4-AF57-482B6D78B784Q37082829-B78C05F2-E0D5-4DCD-A95B-A76CC06B7AA3Q37195404-2F124F7D-55BF-4859-A3A8-737B99C95F14Q37418872-9D6B054A-881F-4A77-87CB-692F266F7468Q37471756-55CD3F2C-1A8D-4AD2-BEA5-A48CBEEE42D2Q37638675-60088B4B-E1E5-460D-8B08-3621E1405EE7Q37722763-DE1187A3-FCCE-44B0-B72E-92F88A5EFCE1Q37807332-A7D10676-7299-46D9-8CC8-818F3EF48DABQ37833470-4A9159F8-EC5B-459F-A2EB-C082D32545D1
P2860
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy of rosuvastatin among ...... on-an Intervention Trial Evalu
@en
type
label
Efficacy of rosuvastatin among ...... on-an Intervention Trial Evalu
@en
prefLabel
Efficacy of rosuvastatin among ...... on-an Intervention Trial Evalu
@en
P2093
P1476
Efficacy of rosuvastatin among ...... on-an Intervention Trial Evalu
@en
P2093
Jean MacFadyen
Michael Cressman
Paul M Ridker
Robert J Glynn
P304
P356
10.1016/J.JACC.2010.01.020
P407
P577
2010-03-04T00:00:00Z